Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Cook

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biopharmaceutics & Drug Disposition|May 15, 2012
Development strategies for IVIVC in an industrial environmentJack A Cook
The AAPS Journal|April 25, 2012
A technique to estimate in vivo dissolution profiles without data from a solutionJack A Cook
Molecular Pharmaceutics|August 26, 2010
Impact of Biopharmaceutics Classification System-based biowaiversJack A Cook, Barbara M Davit, James E Polli
Journal of Clinical Pharmacology|December 21, 2007
A perspective on the use of concentration-QT modeling in drug developmentTanya Russell, Steven P Riley, Jack A Cook, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2006
Lack of a pharmacokinetic interaction between azithromycin and chloroquineJack A Cook, Edward J Randinitis, Candace R Bramson, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2010
P-glycoprotein related drug interactions: clinical importance and a consideration of disease statesCaroline A Lee, Jack A Cook, Eric L Reyner, et al.
Pharmaceutical Research|December 10, 2003
The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic painPeter A Lockwood, Jack A Cook, Wayne E Ewy, et al.
Contemporary Clinical Trials|June 1, 2022
Ensuring diversity in clinical trials: The role of clinical pharmacologyJoanna C Masters, Jack A Cook, Ginger Anderson, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetics of pregabalin in subjects with various degrees of renal functionEdward J Randinitis, Edward L Posvar, Christine W Alvey, et al.
The AAPS Journal|July 29, 2020
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biopharmaceutics & Drug Disposition|May 15, 2012
Development strategies for IVIVC in an industrial environmentJack A Cook
The AAPS Journal|April 25, 2012
A technique to estimate in vivo dissolution profiles without data from a solutionJack A Cook
Molecular Pharmaceutics|August 26, 2010
Impact of Biopharmaceutics Classification System-based biowaiversJack A Cook, Barbara M Davit, James E Polli
Journal of Clinical Pharmacology|December 21, 2007
A perspective on the use of concentration-QT modeling in drug developmentTanya Russell, Steven P Riley, Jack A Cook, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2006
Lack of a pharmacokinetic interaction between azithromycin and chloroquineJack A Cook, Edward J Randinitis, Candace R Bramson, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2010
P-glycoprotein related drug interactions: clinical importance and a consideration of disease statesCaroline A Lee, Jack A Cook, Eric L Reyner, et al.
Pharmaceutical Research|December 10, 2003
The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic painPeter A Lockwood, Jack A Cook, Wayne E Ewy, et al.
Contemporary Clinical Trials|June 1, 2022
Ensuring diversity in clinical trials: The role of clinical pharmacologyJoanna C Masters, Jack A Cook, Ginger Anderson, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetics of pregabalin in subjects with various degrees of renal functionEdward J Randinitis, Edward L Posvar, Christine W Alvey, et al.
The AAPS Journal|July 29, 2020
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug ProductsArzu Selen, Anette Müllertz, Filippos Kesisoglou, et al.
Pageof 3